|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 3 (August 1), 1999:
pp. 959-967
Homocysteine-Induced Endoplasmic Reticulum Stress and Growth Arrest
Leads to Specific Changes in Gene Expression in Human Vascular
Endothelial Cells
By
P. Andrew Outinen,
Sudesh K. Sood,
Sabine I. Pfeifer,
Sushmita Pamidi,
Thomas J. Podor,
Jun Li,
Jeffrey I. Weitz, and
Richard C. Austin
From the Department of Pathology and Molecular Medicine, McMaster
University and the Hamilton Civic Hospitals Research Centre, Hamilton,
Ontario, Canada.
 |
ABSTRACT |
Alterations in the cellular redox potential by homocysteine promote
endothelial cell (EC) dysfunction, an early event in the progression of
atherothrombotic disease. In this study, we demonstrate that
homocysteine causes endoplasmic reticulum (ER) stress and growth arrest
in human umbilical vein endothelial cells (HUVEC). To determine if
these effects reflect specific changes in gene expression, cDNA
microarrays were screened using radiolabeled cDNA probes generated from
mRNA derived from HUVEC, cultured in the absence or presence of
homocysteine. Good correlation was observed between expression profiles
determined by this method and by Northern blotting. Consistent with its
adverse effects on the ER, homocysteine alters the expression of genes
sensitive to ER stress (ie, GADD45, GADD153, ATF-4, YY1). Several other genes observed to be differentially expressed by homocysteine are known
to mediate cell growth and differentiation (ie, GADD45, GADD153, Id-1,
cyclin D1, FRA-2), a finding that supports the observation that
homocysteine causes a dose-dependent decrease in DNA synthesis in
HUVEC. Additional gene profiles also show that homocysteine decreases
cellular antioxidant potential (glutathione peroxidase, NKEF-B PAG,
superoxide dismutase, clusterin), which could potentially enhance the
cytotoxic effects of agents or conditions known to cause oxidative
damage. These results successfully demonstrate the use of cDNA
microarrays in identifying homocysteine-respondent genes and indicate
that homocysteine-induced ER stress and growth arrest reflect specific
changes in gene expression in human vascular EC.
© 1999 by The American Society of Hematology.
| |
INTRODUCTION |
HYPERHOMOCYST(E)INEMIA (HH) is a
significant independent risk factor for premature atherothrombotic
disease.1-5 Up to 40% of patients diagnosed with coronary,
cerebrovascular, or peripheral atherosclerosis have HH.3-6
Although the majority of cases of HH are thought to be caused by an
interplay between dietary and genetic factors, the genetic disorders
are associated with the highest plasma levels of homocysteine, with
cystathionine  -synthase deficiency (CBS)4-6 and
5,10-methylenetetrahydrofolate reductase deficiency7,8
being the most common. Regardless of the underlying cause of HH, the
relationship between elevated blood homocysteine levels and premature
vascular and thrombotic disease persists.
Earlier studies suggest that atherothrombosis associated with HH
reflects endothelial cell (EC) injury and/or dysfunction. Homocysteine
causes EC injury when administered to baboons9,10 or
rats,11 or when added directly to cultured
EC.12-15 Furthermore, deGroot et al14 showed
that primary cultures of EC obtained from obligate heterozygotes for
CBS deficiency are more sensitive to homocysteine-induced damage than
control cells. In addition to causing injury, homocysteine has been
shown to increase the procoagulant activity of cultured EC by (1)
inducing a protease that activates factor V,16 (2)
inhibiting protein C activation,17 (3) causing aberrant
processing of thrombomodulin (TM),18 (4) inducing tissue
factor activity,19 and (5) inhibiting the cellular binding
sites for tissue plasminogen activator.20 Homocysteine also
reduces nitric oxide production in vitro,21 a finding that could explain why diet-induced HH in monkeys22 and
pigs23 causes impaired vasomotor regulatory function.
Currently, the mechanism by which elevated levels of homocysteine cause
EC injury and/or dysfunction is relatively unknown. We, and others,
have demonstrated in cultured human vascular EC that homocysteine
increases the expression and synthesis of GRP78, an endoplasmic
reticulum (ER)-resident chaperon and member of the 70-Kd heat-shock
protein (HSP) family.24-26 In support of these in vitro
findings, steady-state mRNA levels of GRP78 were also shown to be
elevated in the livers of CBS-deficient mice that had HH.26
Given that GRP78 is induced by agents or conditions known to elicit ER
stress27 and that homocysteine impairs protein processing
and secretion via the ER,18,28 these studies suggest that
homocysteine alters the cellular redox state, thereby causing ER stress
and leading to growth arrest.29 Whether these effects of
homocysteine reflect specific changes in gene expression is not
completely known.
To explore this possibility, cDNA microarrays were screened using
radiolabeled cDNA probes generated from mRNA transcripts from human
vascular EC cultured in the absence or presence of homocysteine.
Herein, we provide a first step in identifying the gene pathways by
which homocysteine alters EC function and show that
homocysteine-induced ER stress and growth arrest reflect changes in
gene expression specific for these effects. Furthermore, additional
gene pathways demonstrate that homocysteine decreases the expression of
a wide range of antioxidant enzymes that could enhance the adverse
effects of agents and/or conditions known to cause oxidative damage.
| |
MATERIALS AND METHODS |
Cell culture and treatment conditions.
Primary human umbilical vein endothelial cells (HUVEC) were isolated by
collagenase treatment of human umbilical veins30 and
cultured in EC medium (M199 medium containing 20% fetal bovine serum,
20 µg/mL EC growth factor, 90 µg/mL porcine intestinal heparin, 100 µg/mL penicillin, and 100 µg/mL streptomycin) in a humidified
incubator at 37°C with 5% CO2. Cells from passages 2 to 4 were used in these studies. The transformed HUVEC line, ECV304,
was obtained from the American Type Culture Collection (ATCC;
Rockville, MD) and cultured in EC medium. DL-Homocysteine or
dithiothreitol (DTT) (Sigma, St Louis, MO) was prepared in EC medium,
sterilized by filtration, and added to the cell cultures.
[3H]thymidine incorporation.
HUVEC were grown to 70% confluency in EC medium in the absence or
presence of increasing concentrations of homocysteine or DTT (0.2 to
5.0 mmol/L) for 18 hours. During the last 4 hours of treatment, cells
were labeled with [methyl-3H]thymidine (NEN Life
Sciences, Guelph, Canada) at 1 µCi/mL. After labeling, cells were
washed 3 times with phosphate-buffered saline (PBS), fixed in ice-cold
10% acetic acid, and washed with 95% ethanol. Incorporated
[3H]thymidine was extracted in 0.2N NaOH and measured in
a scintillation counter. Values were expressed as the mean ± SD
from 3 separate experiments.
Metabolic labeling and immunoprecipitation.
HUVEC grown to 70% confluence in EC medium were cultured in the
absence or presence of increasing concentrations of homocysteine (0.2 to 5.0 mmol/L) for 8 or 18 hours. Cells were then metabolically labeled
with 300 µCi/flask of EXPRE35S35S labeling
mix (NEN) in Dulbecco's modified Eagle's medium (DMEM) without
methionine or cysteine for 1 hour. Cell lysates were prepared in 1 mL
of lysis buffer (1% Triton-X100 in 25 mmol/L Tris, 100 mmol/L NaCl,
0.02% bovine serum albumin, 10 mmol/L EDTA, pH 8.0) that contained
protease inhibitors, centrifuged to precipitate insoluble material, and
incubated with protein A-Sepharose beads (Amersham Pharmacia
Biotech, Mississauga, Canada) to remove any material that binds
nonspecifically to protein A. Samples were then incubated with either
goat anti-von Willebrand factor (anti-vWF) antibodies (Affinity
Biologicals, Hamilton, Canada) or control goat IgG in the presence of
protein A-Sepharose overnight at 4°C. After washing with PBS, the
beads were boiled in sodium dodecyl sulfate polyacrylamide gel
electropheresis (SDS-PAGE) sample buffer (50 mmol/L Tris, pH 6.8, 2%
SDS, 10% glycerol, 1% -mercaptoethanol, 0.01% bromophenol blue)
and proteins separated on 7.5% SDS-polyacrylamide gels under reducing
conditions. Radiolabeled proteins were detected by fluorography after
incubation with Amplify (Amersham Pharmacia Biotech).
vWF multimer analysis.
Whole-cell lysates were prepared by denaturation of HUVEC in lysis
buffer that contained 1 mg/µL urea and 0.1% SDS. vWF multimers were
separated on 1.2% agarose gels in 1X electrophoresis buffer (50 mmol/L
Tris, 0.384 mol/L glycine, 0.1% SDS, pH 8.3) run at 35 V
overnight or until the buffer front was within 1 to 2 cm from the
anodal end of the gel. For detection of vWF, proteins were
electrophoretically transferred to nitrocellulose membranes, immunoblotted with anti-vWF antibodies, and visualized using the Renaissance chemiluminescence reagent (NEN).
Immunohistochemistry and image analysis.
Immunohistochemistry and image analysis was performed as described
previously.26 Briefly, after fixation and permeabilization, HUVEC were immunostained with either anti-GRP78 (StressGen, Vancouver, Canada) or anti-vWF antibodies and images captured using Northern Exposure image analysis/archival software (Mississauga, Canada).
Preparation of total RNA.
Total RNA was isolated from cells using the RNeasy total RNA kit
(Qiagen, Santa Clarita, CA) and resuspended in diethyl pyrocarbonate (DEPC)-treated water. Quantification and purity of the RNA was assessed
by A260/A280 absorption, and RNA samples with
ratios greater than 1.6 were stored at  70°C for further analysis.
Analysis of differential gene expression using a human cDNA
microarray.
Poly (A)+ RNA was isolated from total RNA using Oligotex
resin (Qiagen), as described previously.26 To generate
radiolabeled cDNA probes, poly (A)+ RNA was
reverse-transcribed with Moloney murine leukemia virus (MMLV) in the
presence of [ -32P]dATP (NEN). The radiolabeled cDNA
probes were purified from unincorporated nucleotides by gel filtration
in Chroma Spin-200 columns (Clontech, Palo Alto, CA) and hybridized
overnight at 68°C to a human cDNA microarray consisting of 588 known human genes under tight transcriptional control, as described by
the manufacturer (Clontech). After a series of high-stringency washes (three 20-minute washes in 2X saline-sodium citrate
[SSC], 1% SDS followed by two 20-minute washes in 0.1X
SSC, 0.5% SDS) at 68°C, the membranes were exposed to x-ray film
(Reflections NEF-496, NEN) and subjected to autoradiography. Changes in
gene expression were quantified by densitometric scanning of the
membranes using the ImageMaster VDS and Analysis Software (Amersham
Pharmacia Biotech).
Northern blot analysis.
Total RNA (10 µg/lane) was fractionated on 2.2 mol/L
formaldehyde/1.2% agarose gels and transferred overnight onto
Zeta-Probe GT nylon membranes (Bio-Rad, Toronto, Canada) in 10X SSC.
The RNA was cross-linked to the membrane using a UV crosslinker (PDI Bioscience, Toronto, Canada) before hybridization. Specific probes were
generated by labeling the cDNA fragments with
[-32P]dCTP (NEN) using a random primed DNA labeling
kit (Boehringer Mannheim, Laval, Canada). After overnight hybridization
at 43°C, the membranes were washed as described by the
manufacturer, exposed to x-ray film, and subjected to autoradiography.
Changes in steady-state mRNA levels were quantified by densitometric
scanning of the blots as described earlier. To correct for differences
in gel loading, integrated optical densities were normalized to human
glyceraldehyde 3-phosphate dehydrogenase (GAPDH). cDNA probes encoding
Id-1 (GenBank/EBI accession no. AA582212), natural killer
cell-enhancing factor B (NKEF-B) (no. AA100194),
proliferation-associated protein (PAG) (no. AA204896), sterol
regulatory element-binding protein 1 (SREBP) (no. AA568572), clusterin
(no. AA614020), growth arrest and DNA damage-inducible (GADD) genes,
GADD153 (no. AA627477) and GADD45 (no. AA147214) were obtained from
Genome Systems (St Louis, MO). The cDNA probe encoding GRP78 has been
described previously.26
Statistical analysis.
Data are presented as the mean ± SD. Statistical differences
between the homocysteine-treated and control groups were determined by
analysis of variance. If a significant difference between treated and
control groups was demonstrated, an unpaired Student's t-test was performed for each point. For all analyses, P values less than .05 were considered statistically significant.
| |
RESULTS |
Effect of homocysteine on HUVEC viability and growth.
To examine the effect of homocysteine on cell viability,
51Cr release assays were performed as described
previously.14 Exposure of HUVEC to 5 mmol/L homocysteine
for up to 18 hours had no significant effect on overall cell viability,
compared with control cells (19.3% ± 0.5% v 17.4% ± 0.6% release, respectively, at 6 hours, n = 3; 27.9% ± 2.3%
v 28.1% ± 0.7% release, respectively, at 18 hours, n = 3). The time-dependent basal release of 51Cr from HUVEC is
consistent with previous studies.14 In contrast to 5 mmol/L
homocysteine alone, 5 mmol/L homocysteine in the presence of
4 µmol/L Cu2+, which is known to generate
H2O2 and induce EC lysis,12-15
caused a significant increase (P > .01) in the release of
51Cr at 18 hours (28.1% ± 0.7% v 81.4% ± 1.2% release, respectively, n = 3).
To determine the effect of homocysteine on cell proliferation, HUVEC
were cultured in the absence or presence of various concentrations of
homocysteine and [3H]thymidine incorporation was
measured. As shown in Fig 1, HUVEC exposed
to homocysteine for 18 hours demonstrated a dose-dependent decrease in
DNA synthesis and is consistent with earlier studies.29 In
addition to homocysteine, the thiol-containing reducing agent DTT also
caused a similar dose-dependent decrease in DNA synthesis (data not
shown).
View larger version (13K):
[in this window]
[in a new window]
| Fig 1.
Effect of homocysteine on DNA synthesis. Primary HUVEC
were incubated in EC medium in the absence or presence of increasing
concentrations of homocysteine for 18 hours.
[3H]thymidine incorporation was measured during the last
4 hours. Values represent the mean ± SD from 3 wells from 3 separate
experiments. * P < .05 v untreated HUVEC, **P
< .01.
|
|
Homocysteine induces ER stress in HUVEC.
Previous studies have shown that intracellular transport of vWF and TM
via the ER is selectively inhibited by homocysteine in
HUVEC.18,28 Homocysteine also increases the expression and synthesis of GRP78, a resident ER chaperon induced by agents or conditions known to adversely affect ER function.24-26 To
further investigate the effect of homocysteine on ER function, vWF
processing and secretion, and its interaction with GRP78 were examined
in HUVEC cultured in the absence or presence of homocysteine.
The effect of homocysteine on intracellular levels and distribution of
GRP78 and vWF in HUVEC was examined by indirect immunofluorescence using anti-vWF or anti-GRP78 antibodies. In control HUVEC, GRP78 was
concentrated in the perinuclear region, consistent with its presence in
the ER (Fig 2A). In contrast, both the
distribution and intensity of GRP78 immunostaining was markedly
enhanced in HUVEC exposed to homocysteine (Fig 2B). Unlike GRP78, vWF
immunostaining and localization were dramatically reduced in HUVEC
exposed to homocysteine (Fig 2E), compared with control cells (Fig 2D).
As controls, no specific staining was observed in untreated HUVEC incubated with either normal mouse (Fig 2C) or rabbit IgG (Fig 2F).
Consistent with these findings, intracellular levels of vWF dimers were
dramatically decreased after 4 hours in HUVEC exposed to 5 mmol/L
homocysteine (Fig 3).
View larger version (75K):
[in this window]
[in a new window]
| Fig 2.
Effect of homocysteine on the cellular localization of
GRP78 and vWF. HUVEC plated on gelatin-coated glass coverslips were
cultured in the absence (A,D) or presence (B,E) of 5.0 mmol/L
homocysteine for 18 hours. After treatment, cells were fixed,
permeabilized, and incubated with antibodies against either GRP78 (A,B)
or vWF (D,E). Antibodies were subsequently detected using
fluorescein-labeled secondary antibodies. Parallel experiments using
normal mouse (C) or rabbit IgG (D) were performed to assess nonspecific
immunofluorescence.
|
|
View larger version (61K):
[in this window]
[in a new window]
| Fig 3.
Effect of homocysteine on vWF multimerization. HUVEC
cultured in the absence or presence of 5.0 mmol/L homocysteine for 1, 2, 4, 8, or 18 hours were denatured in lysis buffer, the lysates
fractionated on 1.2% (wt/vol) agarose gels and transferred to
nitrocellulose. vWF monomers, dimers, and multimers were detected by
immunoblotting using anti-vWF antibodies.
|
|
Stable association of GRP78 with misfolded, improperly glycosylated, or
incompletely assembled proteins in the ER leads to retention and
intracellular degradation.31-33 To determine whether GRP78
was capable of stably binding to misfolded vWF within the ER, HUVEC
exposed to various concentrations of homocysteine for 8 or 18 hours
were metabolically labeled with [35S]cysteine and
[35S]methionine, and vWF from cell lysates was
immunoprecipitated with anti-vWF antibodies as described in the
Methods. Bands that corresponded to mature and pro-vWF were detected in
immunoprecipitated eluates from HUVEC treated without or with
homocysteine (Fig 4). However, coimmunoprecipitation of
vWF with GRP78 was observed only in HUVEC treated with 1 or 5 mmol/L
homocysteine for 8 hours or 5 mmol/L homocysteine for 18 hours. Taken
together, these findings imply that GRP78 binds to misfolded vWF,
prevents its secretion from the ER and likely directs aberrantly folded
vWF to the degradative machinery.
View larger version (73K):
[in this window]
[in a new window]
| Fig 4.
Homocysteine increases the stable association between
GRP78 and vWF. HUVEC cultured in the absence or presence of 0.2, 1.0, or 5.0 mmol/L homocysteine for 8 or 18 hours were metabolically labeled
for 1 hour in the presence of [35S]methionine and
[35S]cysteine. Radiolabeled proteins from cell lysates
were immunoprecipitated with anti-vWF antibodies, separated on 7.5%
SDS polyacrylamide gel under reducing conditions, and detected by
fluorography. Immunoprecipitation of pro and mature vWF coprecipitated
GRP78. kD, molecular mass markers.
|
|
Effect of homocysteine on differential gene expression in HUVEC.
Previous studies have shown that cDNA arrays provide a rapid and
effective method in monitoring differential gene
expression.34-38 To investigate the possibility that
homocysteine-induced ER stress and growth arrest reflect
specific changes in gene expression in ECs, a human cDNA microarray
that contained 588 known human genes was screened using radiolabeled
cDNA generated from total poly (A)+ RNA from primary HUVEC
cultured in the absence or presence of 5 mmol/L homocysteine for 4 or
18 hours. After hybridization, the cDNA array membranes were washed
under high stringency and the hybridization patterns analyzed by
autoradiography. The level of nonspecific hybridization was low since
the negative DNA controls, including M13mp18(+) strand DNA,  DNA, and
pUC18, failed to show any hybridization signal. To ensure accurate
comparisons in the expression levels of each gene on the cDNA array,
hybridization signals were normalized to the signals obtained from
housekeeping gene controls (ie, ubiquitin, glyceraldehyde 3-phosphate
dehydrogenase, -tubulin, human leukocyte antigen [HLA] class 1 histocompatibility antigen C-4, -actin, 23-Kd highly basic protein,
ribosomal protein S9) on the same array.
As shown in Fig 5, the hybridization
patterns between wild-type and homocysteine-treated HUVEC were similar.
However, analysis of the cDNA microarray showed that a total of 16 of
588 (2.7%) of the known human genes were differentially expressed in
primary HUVEC exposed to 5 mmol/L homocysteine for 4 or 18 hours (Table 1). Similar changes in gene expression were
also observed in the ECV304 cell line cultured in the absence or
presence of homocysteine (data not shown). The percentage change in
gene expression observed in this study is consistent with the recent
observation that 2.5% of genes are regulated in HepG2 hepatoma cells
exposed to -mercaptoethanol, another thiol-containing agent known to
cause ER stress and growth arrest.39 Of these genes, 9 were
shown to be induced by homocysteine, while 7 were downregulated. Among
the genes detected with significantly higher expression (>10-fold)
was GADD153, a stress-response gene known to be induced by agents or
conditions that adversely affect ER function.40 ATF-4, a
stress-inducible transcription factor, was also shown to be induced by
homocysteine and is consistent with earlier studies using mRNA
differential display to identify ATF-4 as a homocysteine-inducible
gene.24 Other inducible genes included Id-1, guanine
nucleotide-binding protein G-S, SREBP, transcriptional repressor
protein YY1, and the transcription factor ETR103. Genes shown to be
downregulated by homocysteine included the antioxidant enzymes NKEF-B,
superoxide dismutase, glutathione peroxidase, clusterin, and PAG, as
well as FRA-2, adenosine triphosphate (ATP)-dependent DNA helicase, and
cyclin D1. The observation that the majority of significant changes in
gene expression occurred at 4 hours and declined by 18 hours suggests
that homocysteine causes an initial early response in EC gene
expression, followed by an adaptive response that likely involves
cellular factors that influence the metabolism or elimination of
intracellular homocysteine.
View larger version (43K):
[in this window]
[in a new window]
| Fig 5.
cDNA microarray analysis of changes in gene expression in
primary HUVEC cultured in the absence or presence of homocysteine.
[32P]-labeled cDNA probes generated from poly
(A)+ RNA from control HUVEC (A) or HUVEC exposed to
5 mmol/L homocysteine for either 4 (B) or 18 hours (C) were hybridized
to a cDNA microarray containing 588 known human genes. After a series
of high-stringency washes, hybridization patterns were analyzed by
autoradiography. Upward or downward arrows indicate the location
within the array of genes increased or decreased, respectively, by
homocysteine at 4 or 18 hours, v untreated cells. The relative
expression levels of specific cDNAs was assessed by comparison with a
wide range of housekeeping genes. Results are representative of 2 separate hybridization experiments.
|
|
View this table:
[in this window]
[in a new window]
|
Table 1.
Identification of Homocysteine-Respondent Genes Using
cDNA Microarrays in Primary HUVECs Exposed to 5 mmol/L Homocysteine for
4 or 18 Hours
|
|
To test the reliability of the cDNA microarrays in identifying
differentially expressed genes, we analyzed 7 different
homocysteine-responsive genes by Northern blot analysis (Fig
6A). In each case, the relative expression
levels of these homocysteine-responsive genes observed on Northern
blots was consistent with the differential gene expression identified
by microarray hybridization (Table 2). As a
positive control, homocysteine was shown to induce the expression of
GRP78 (Fig 6B), a finding consistent with our earlier
studies.26
View larger version (26K):
[in this window]
[in a new window]
| Fig 6.
Northern blot analysis substantiating the
consistency of the cDNA microarray results. Total RNA (10 µg/lane)
isolated from HUVEC cultured in the absence or presence of homocysteine
for the indicated time periods was analyzed by Northern blot
hybridization, followed by autoradiography. (A) Effect of homocysteine
on Id-1, NKEFB, clusterin, PAG, SREBP, GADD153, and GADD45 mRNA levels.
(B) Effect of homocysteine on GRP78 mRNA levels.
Hybridization to a human GAPDH probe was used to normalize RNA loading.
The results are representative of 2 separate experiments using 2 different samples of RNA.
|
|
| |
DISCUSSION |
Previous studies using cultured human vascular EC have shown that
alterations in the cellular redox potential by homocysteine impair
protein processing and secretion via the ER18,28 and increase expression of the ER stress-response gene,
GRP78.24-26 In this study, we demonstrate that homocysteine
causes ER stress in cultured human vascular EC by (1) decreasing
intracellular levels of vWF, (2) inducing the expression and synthesis
of GRP78, and (3) increasing the stable association of vWF with GRP78.
Furthermore, homocysteine was shown to cause a dose-dependent decrease
in DNA synthesis, a result consistent with earlier
findings.29 Taken together, these findings both support and
extend previous studies using cultured vascular
EC18,24-26,28 and suggest that homocysteine acts
intracellularly by altering the cellular redox state, thereby leading
to ER stress and growth arrest in EC.
To determine if homocysteine-induced ER stress and growth arrest
results in specific changes in gene expression in EC, cDNA microarrays
were screened. This approach was taken based on previous studies
showing that cDNA microarrays provide a powerful approach for studying
differential gene expression associated with the pathogenesis of cancer
and other diseases.34-38 As a result of this analysis, we
demonstrate that the effects of homocysteine on ER function and cell
growth reflect specific changes in gene expression. Furthermore,
additional gene profiles indicate that homocysteine suppresses the
ability of EC to protect themselves from agents or conditions known to
elicit oxidative damage.
Although relatively high concentrations of homocysteine ( 1 mmol/L)
were used to evaluate changes in gene expression, there was no effect
on overall cell viability, a finding consistent with previous studies
that indicated EC from normal individuals are relatively resistant to
high doses of homocysteine.12-19 This may reflect the fact
that only a small percentage of exogenous homocysteine (<1%) added
to the culture medium is actually taken up
intracellularly.41 Indeed, we have shown that intracellular concentrations of homocysteine are increased only 2-fold and 5-fold in
HUVEC exposed to 1 or 5 mmol/L homocysteine, respectively, compared
with untreated cells.26 Thus, the high doses required to
alter gene expression in vitro likely reflects the need to increase
intracellular levels of homocysteine by overcoming the cellular factors
that influence the metabolism and/or elimination of homocysteine.
The observation that homocysteine induces the expression of GADD45,
GADD153, ATF-4, and YY1 provides genetic evidence that homocysteine
causes ER stress. Although GADD45, a downstream effector of p53, and
GADD153, a member of the C/EBP gene family of transcription factors,42 have also been shown to be induced by growth
arrest, by DNA damage, or by UV irradiation,43-45 recent
studies indicate that inducers of GRP78 increase the expression of
these genes,46 and that the induction of GADD153 is more
responsive to ER stress.40 Based on previous studies
demonstrating that DTT, a thiol-containing agent known to cause ER
stress, induces the expression of both GRP78 and GADD153,47
our findings are not unexpected. Although the physiologic significance
of GADD gene induction by homocysteine has not been defined,
overexpression of the GADDs causes growth arrest in several cell
types.48,49 Furthermore, the importance of GADD153 in
cellular growth and differentiation comes from the molecular analysis
of human sarcomas wherein the rearrangement of the GADD153 gene gives
rise to a naturally occurring altered form of GADD153 incapable of
eliciting growth arrest.50 Given our findings, as in other
studies,29 that homocysteine inhibits EC growth, the GADDs
may play a potential role in linking ER stress to alterations in cell
growth and proliferation. This concept is also supported by our
observation that DTT, a known inducer of ER stress,27 also
decreases EC proliferation. The homocysteine-induced expression of
ATF-4, a member of the activating transcription factor/cyclic adenosine
monophosphate (cAMP)-responsive element-binding protein (ATF/CREB)
family of transcription factors, is consistent with previous
studies.24 ATF-4 is induced by increased intracellular Ca2+ concentrations51 and by
anoxia,52 conditions known to alter ER function. YY1, a
member of the GLI zinc finger family, has been shown to specifically
enhance the transcriptional activation of the GRP78 promoter under a
variety of ER stress conditions.53 These include depletion
of ER Ca2+ stores, inhibition of glycosylation and
formation of misfolded proteins. Thus, the ability homocysteine to
increase the expression of YY1 would not only enhance the expression of
GRP78, but could potentially mediate stress signals generated from the
ER to the nucleus. Given that YY1 affects cell growth54 and
acts as a transcriptional repressor,55 the induction of
YY1, like the GADD genes, by homocysteine may also play a role in
mediating EC growth.
Alterations in the expression of genes known to mediate cell growth and
differentiation is consistent with the finding that homocysteine causes
a dose-dependent decrease in EC growth. Overexpression of Id-1, a
member of the helix-loop-helix transcriptional
regulators,56 suppresses cell differentiation in mammary
epithelial cells57 and murine erythroleukemia
cells.58 The ability of homocysteine to decrease cyclin D1,
a positive growth regulator during the early G1
phase,27 and FRA-2, a transcription factor known to promote
osteoblast differentiation,59 also suggests that
homocysteine affects the expression of growth response genes in ECs.
Whether a decrease in cell growth plays a role in protecting EC from
homocysteine-induced injury and/or dysfunction is currently unknown.
The ability of homocysteine to inhibit the expression of the
antioxidant enzymes glutathione peroxidase and NKEF-B are consistent with our previous findings26 and suggest that homocysteine
may promote EC dysfunction and/or injury by indirectly enhancing the cytotoxic effect of agents or conditions that cause oxidative stress.
This concept is further supported by the recent observation that
homocysteine impairs the ability of glutathione peroxidase to detoxify
peroxides60 and acts synergistically with
H2O2 to enhance mitochondrial
damage.61 In addition to these antioxidant enzymes,
homocysteine decreased the expression of clusterin and PAG. Clusterin,
a multifunctional heterodimeric glycoprotein, has been implicated in a
wide range of physiologic functions such as lipid transport, tissue
repair and remodelling, membrane protection, and promotion of cell
interactions.62 Recent studies have also demonstrated that
induction of clusterin during the development of atherosclerosis may
represent a protective response to the oxidative stress associated with
the development of atherosclerosis.63,64 Furthermore,
because clusterin is a novel potent inhibitor of complementation-mediated cytolysis, the ability of homocysteine to
decrease clusterin gene expression could potentially enhance complement
activation at the site of vessel wall damage, which results in
increased EC injury and/or dysfunction. PAG, a novel antioxidative
protein family member responsive to oxidative stress,65-67 induces cell growth and differentiation by blocking c-Abl
tyrosine kinase activity. The ability of homocysteine to decrease
PAG expression would not only enhance the cytotoxic effects of oxidants
but could suppress EC growth and differentiation.
Although we have identified several gene pathways by which homocysteine
could potentially influence EC function and growth, a number of
relevant issues remain to be explored. Additional studies are needed to
determine if these homocysteine-dependent changes in gene expression in
cultured vascular EC are observed in vivo. The fact that GRP78 is
induced in the livers of CBS-deficient mice,26 and that the
activity of several antioxidant enzymes is altered in rabbits fed a
high methionine diet68 supports our findings and suggests
that our in vitro studies likely reflect the actions of homocysteine in
vivo. Furthermore, it is not known if the ability of homocysteine to
cause ER stress directly influences EC growth. Based on the observation
that agents known to adversely affect ER function cause inhibition of
protein synthesis69 and cell growth,70-72 it is
likely that elevated levels of intracellular homocysteine act in a
similar fashion. As a result of previous studies demonstrating that
homocysteine induces smooth muscle cell proliferation and increases the
expression of the cyclin genes,29 it will be of interest to
determine if the changes in gene expression observed in smooth muscle
cells by homocysteine inversely correlate with some of the genes
identified in these studies.
In summary, we have shown that homocysteine-induced ER stress and
growth arrest in vascular EC involves changes in gene expression specific for these effects. Furthermore, the ability of homocysteine to
decrease the expression of several antioxidant enzymes suggests that
homocysteine could indirectly enhance the effects of agents or
conditions known to cause oxidative stress. We also show the utility of
cDNA microarrays as an initial screening approach for the
identification of homocysteine-respondent genes in EC. Based on the
high yield of information obtained using an array of fewer than 600 known human genes, a more comprehensive survey of gene expression
patterns, using a more complete array of human genes, will not only
provide additional important information on the mechanism by which
homocysteine promotes EC dysfunction but will also increase our
understanding of the gene pathways involved in the pathogenesis of HH.
| |
ACKNOWLEDGMENT |
We thank Dr Catherine Hayward for technical assistance in analyzing the
vWF multimers.
| |
FOOTNOTES |
Submitted August 24, 1998; accepted March 29, 1999.
Supported by Research Grant No. NA-3307 from the Heart and Stroke
Foundation of Ontario (to R.C.A.). P.A.O. was a recipient of a Douglas
C. Russel Memorial Scholarship and an Ontario Graduate Scholarship.
R.C.A. is a Research Scholar of the R.K. Fraser Foundation.
The publication costs of this
article were defrayed in part by
page charge payment. This article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. section
1734 solely to indicate this fact.
Address reprint requests to Richard C. Austin, PhD, Hamilton Civic
Hospitals Research Centre, 711 Concession St, Hamilton, Ontario,
Canada, L8V 1C3; e-mail: raustin{at}thrombosis.hhscr.org.
| |
REFERENCES |
1.
Ueland PM, Refsum H, Brattstrom L:
Plasma homocysteine and cardiovascular disease, in
Francis RB Jr
(ed):
Atherosclerotic Cardiovascular Disease, Hemostasis and Endothelial Function. New York, NY, Dekker, 1993, p 183.
2.
Kang S-S, Wong PWK, Malinow MR:
Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease.
Annu Rev Nutr
12:279, 1992[Medline]
[Order article via Infotrieve]
3.
Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH:
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis.
N Engl J Med
332:286, 1995[Abstract/Free Full Text]
4.
Mayer EL, Jacobsen DW, Robinson K:
Homocysteine and coronary atherosclerosis.
J Am Coll Cardiol
27:517, 1996[Abstract]
5.
McCully KS:
Homocysteine and vascular disease.
Nature Med
2:386, 1996[Medline]
[Order article via Infotrieve]
6.
D'Angelo A, Selhub J:
Homocysteine and thrombotic disease.
Blood
90:1, 1997[Free Full Text]
7.
Engbersen AMT, Franken DG, Boers GHJ, Stevens EMB, Trijbels FJM, Blom HJ:
Thermolabile 5,10-methylene tetrahydrofolate reductase as a cause of mild hyperhomocysteinemia.
Am J Hum Genet
56:142, 1995[Medline]
[Order article via Infotrieve]
8.
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJM, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R:
A candidate risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase.
Nature Genet
10:111, 1995[Medline]
[Order article via Infotrieve]
9.
Harker LA, Slichter SJ, Scott CR, Ross R:
Homocysteinemia: Vascular injury and arterial thrombosis.
N Engl J Med
291:537, 1974
10.
Harker LA, Harlan JM, Ross R:
Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons.
Circ Res
53:731, 1983[Abstract/Free Full Text]
11.
Hladovec J:
Experimental homocysteinemia, endothelial lesions and thrombosis.
Blood Vessels
16:202, 1979[Medline]
[Order article via Infotrieve]
12.
Wall RT, Harlan JM, Harker LA, Striker GE:
Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury.
Thromb Res
18:113, 1980[Medline]
[Order article via Infotrieve]
13.
Starkebaum G, Harlan JM:
Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.
J Clin Invest
77:1370, 1986
14.
de Groot PG, Willems C, Boers GHJ, Gonsalves MD, VanAken WG, Mourik JA:
Endothelial cell dysfunction in homocystinuria.
Eur J Clin Invest
13:405, 1983[Medline]
[Order article via Infotrieve]
15.
Dudman NPB, Hicks C, Wang J, Wilcken DEL:
Human arterial endothelial cell detachment in vitro: Its promotion by homocysteine and cysteine.
Atherosclerosis
91:77, 1991[Medline]
[Order article via Infotrieve]
16.
Rodgers GM, Kane WH:
Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.
J Clin Invest
77:1909, 1986
17.
Rodgers GM, Conn MT:
Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells.
Blood
75:895, 1990[Abstract/Free Full Text]
18.
Lentz SR, Sadler JE:
Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine.
J Clin Invest
88:1906, 1991
19.
Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM:
Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells.
Arterioscler Thromb
13:1327, 1993[Abstract/Free Full Text]
20.
Hajjar KA, Mauri L, Jacovina AT, Zhong F, Mirza UA, Padovan JC, Chait BT:
Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine.
J Biol Chem
273:9987, 1998[Abstract/Free Full Text]
21.
Stamler JS, Osborne JA, Jaraki O, Rabbini LE, Mullins M, Singel S, Loscalzo J:
Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.
J Clin Invest
91:308, 1993
22.
Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD:
Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
J Clin Invest
98:24, 1996[Medline]
[Order article via Infotrieve]
23.
Rolland PH, Friggi A, Barlatier A, Piquet P, Latrille V, Faye MM, Guillou J, Charpiot P, Bodard H, Ghiringhelli O, Calaf R, Luccioni R, Garcon D:
Hyperhomocysteinemia-induced vascular damage in the mini-pig.
Circulation
91:1161, 1995[Abstract/Free Full Text]
24.
Kokame K, Kato H, Miyata T:
Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis: GRP78 and novel genes.
J Biol Chem
271:29659, 1996[Abstract/Free Full Text]
25.
Miyata T, Kokame K, Agarwala KL, Kato H:
Analysis of gene expression in homocysteine-injured vascular endothelial cells: Demonstration of GRP78/BiP expression, cloning and characterization of a novel reducing agent-tunicamycin regulated gene.
Semin Thromb Hemost
24:285, 1998[Medline]
[Order article via Infotrieve]
26.
Outinen PA, Sood SK, Liaw PCY, Sarge KD, Maeda N, Hirsh J, Ribau J, Podor TJ, Weitz JI, Austin RC:
Characterization of the stress-inducing effects of homocysteine.
Biochem J
332:213, 1998
27.
Lee AS:
Mammalian stress response: induction of the glucose-regulated protein family.
Curr Opin Cell Biol
4:267, 1992[Medline]
[Order article via Infotrieve]
28.
Lentz SR, Sadler JE:
Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum.
Blood
81:683, 1993[Abstract/Free Full Text]
29.
Tsai J, Perrella CMA, Yoshizumi M, Hseih CM, Haber E, Schlegel R, Lee ME:
Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis.
Proc Natl Acad Sci USA
91:6369, 1994[Abstract/Free Full Text]
30.
Jaffe EA, Nachmann RL, Becker CG, Minick CR:
Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria.
J Clin Invest
52:2745, 1973
31.
Gething M-J, McCammon K, Sambrook J:
Expression of wild-type and mutant forms of influenza hemagglutinin: The role of folding in intracellular transport.
Cell
46:939, 1986[Medline]
[Order article via Infotrieve]
32.
Bole DG, Hendershot LM, Keaney JF:
Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas.
J Cell Biol
102:1558, 1986[Abstract/Free Full Text]
33.
Navarro D, Qadri I, Pereira L:
A mutation in the ectodomain of herpes simplex virus 1 glycoprotein B causes defective processing and retention in the endoplasmic reticulum.
Virology
184:253, 1991[Medline]
[Order article via Infotrieve]
34.
Ramsay G:
DNA chips: State-of-the art.
Nature Biotech
16:40, 1998[Medline]
[Order article via Infotrieve]
35.
Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, Woolley DE, Davis RW:
Discovery and analysis of inflammatory disease-related genes using cDNA microarrays.
Proc Natl Acad Sci USA
94:2150, 1997[Abstract/Free Full Text]
36.
DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM:
Use of a cDNA microarray to analyse gene expression patterns in human cancer.
Nature Genet
14:457, 1996[Medline]
[Order article via Infotrieve]
37.
Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RO:
Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes.
Proc Natl Acad Sci USA
93:10614, 1996[Abstract/Free Full Text]
38.
Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL:
Expression monitoring by hybridization to high-density oligonucleotide arrays.
Nature Biotech
14:1675, 1996[Medline]
[Order article via Infotrieve]
39.
Cabibbo A, Consalez GG, Sardella M, Sitia R, Rubartelli A:
Changes in gene expression during the growth arrest of HepG2 hepatoma cells induced by reducing agents or TGF1.
Oncogene
16:2935, 1998[Medline]
[Order article via Infotrieve]
40.
Wang X-Z, Lawson B, Brewer JW, Zinszner H, Sanjay A, Mi L-J, Boorstein R, Kreibich G, Hendershot LM, Ron D:
Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153).
Mol Cell Biol
16:4273, 1996[Abstract]
41.
Hultberg B, Andersson A, Isaksson A:
Metabolism of homocysteine, its relation to the other cellular thiols and its mechanism of cell damage in a cell culture line (human histiocytic cell line U-937).
Biochim Biophys Acta
1269:6, 1995[Medline]
[Order article via Infotrieve]
42.
Ron D, Habener JF:
CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant negative inhibitor of gene transcription.
Genes Dev
6:439, 1992[Abstract/Free Full Text]
43.
Fornace AJ, Nebert DW, Hollander C, Luethy JD, Papathanasiou M, Fargnoli J, Holbrook NJ:
Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents.
Mol Cell Biol
9:4196, 1989[Abstract/Free Full Text]
44.
Luethy JD, Holbrook NJ:
Activation of the gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage.
Cancer Res
52:5, 1992[Abstract/Free Full Text]
45.
Luethy JD, Fargnoli J, Park JS, Fornace AJ, Holbrook NJ:
Isolation and characterization of the hamster gadd153 gene.
J Biol Chem
265:16521, 1990[Abstract/Free Full Text]
46.
Price BD, Calderwood SK:
Gadd45 and Gadd153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of the glucose-regulated proteins.
Cancer Res
52:3814, 1992[Abstract/Free Full Text]
47.
Halleck MM, Liu H, North J, Stevens JL:
Reduction of trans-4,5-dihydroxy-1,2-dithiane by cellular oxidoreductases activates gadd153/chop and grp78 transcription and induces cellular tolerance in kidney epithelial cells.
J Biol Chem
272:21760, 1997[Abstract/Free Full Text]
48.
Zhan Q, Lord KA, Alamo I Jr, Hollander MC, Carrier F, Ron D, Kohn KW, Hoffman B, Liebermann DA, Fornace AJ Jr:
The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth.
Mol Cell Biol
14:2361, 1994[Abstract/Free Full Text]
49.
Barone MV, Crozat AY, Tabaee A, Philipson L, Ron D:
CHOP (GADD153) and its oncogenic variant, TLS-CHOP, differ in their ability to induce G1/S arrest.
Genes Dev
8:453, 1994[Abstract/Free Full Text]
50.
Crozat AY, Aman P, Mandahl N, Ron D:
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma with t(12;16)(q13;p11).
Nature
363:640, 1993[Medline]
[Order article via Infotrieve]
51.
Tsujimoto A, Nyunoya H, Morita T, Sato T, Shimotohno K:
Isolation of cDNAs for DNA-binding proteins which specifically bind to a tax-responsive enhancer element in the long terminal repeat of human T-cell leukemia virus type I.
J Virol
65:1420, 1991[Abstract/Free Full Text]
52.
Estes SD, Stoler DL, Anderson GR:
Normal fibroblasts induce the C/EBP beta and ATF-4 bZIP transcription factors in response to anoxia.
Exp Cell Res
220:47, 1995[Medline]
[Order article via Infotrieve]
53.
Li WW, Hsiung Y, Zhou Y, Roy B, Lee AS:
Induction of the mammalian GRP78/BiP gene by Ca2+ depletion and formation of aberrant proteins: Activation of the conserved stress-inducible grp core promoter element by the human nuclear factor YY1.
Mol Cell Biol
17:54, 1997[Abstract]
54.
Austen M, Cerni C, Henriksson M, Hilfenhaus S, Luscher-Firzlaff JM, Menkel A, Seelos C, Sommer A, Luscher B:
Regulation of cell growth by the Myc-Max-Mad network: Role of Mad proteins and YY1.
Curr Top Microbiol Immunol
224:123, 1997[Medline]
[Order article via Infotrieve]
55.
Galvin KM, Shi Y:
Multiple mechanims of transcriptional repression by YY1.
Moll Cell Biol
17:3723, 1997[Abstract]
56.
Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H:
The protein Id: a negative regulator of helix-loop-helix DNA binding proteins.
Cell
61:49, 1990[Medline]
[Order article via Infotrieve]
57.
Desprez PY, Hara E, Bissell MJ, Campisi J:
Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1.
Mol Cell Biol
15:3398, 1995[Abstract]
58.
Shoji W, Yamamoto T, Obinata M:
The helix-loop-helix protein Id inhibits differentiation of murine erythroleukemia cells.
J Biol Chem
269:5078, 1994[Abstract/Free Full Text]
59.
McCabe LR, Banerjee C, Kundu R, Harrison RJ, Dobner PR, Stein JL, Lian JB, Stein GS:
Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: Role of Fra-2 and Jun D during differentiation.
Endocrinology
137:4398, 1996[Abstract]
60.
Upchurch GR, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF, Loscalzo J:
Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase.
J Biol Chem
272:17012, 1997[Abstract/Free Full Text]
61.
Austin RC, Sood SK, Dorward AM, Singh G, Shaughnessy SG, Pamidi S, Outinen PA, Weitz JI:
Homocysteine-dependent alterations in mitochondrial gene expression, function and structure: homocysteine and H2O2 act synergistically to enhance mitochondrial damage.
J Biol Chem
273:30808, 1998[Abstract/Free Full Text]
62.
Rosenberg ME, Silkensen J:
Clusterin: physiologic and pathophysiologic considerations.
Int J Biochem Cell Biol
27:633, 1995[Medline]
[Order article via Infotrieve]
63.
Mackness B, Hunt R, Durrington PN, Mackness MI:
Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis.
Arterioscler Thromb Vasc Biol
17:1233, 1997[Abstract/Free Full Text]
64.
Schwochau GB, Nath KA, Rosenberg ME:
Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties.
Kidney Int
53:1647, 1998[Medline]
[Order article via Infotrieve]
65.
Wen ST, Van Etten RA:
The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity.
Genes Dev
11:2456, 1997[Abstract/Free Full Text]
66.
Prosperi MT, Ferbus D, Rouillard D, Goubin G:
The pag gene product, a physiological inhibitor of c-abl tyrosine kinase, is overexpressed in cells entering S phase and by contact with agents inducing oxidative stress.
FEBS Lett
423:39, 1998[Medline]
[Order article via Infotrieve]
67.
Siow RC, Ishii T, Sato H, Taketani S, Leake DS, Sweiry JH, Pearson JD, Bannai S, Mann GE:
Induction of the antioxidant stress proteins heme oxygenase-1 and MSP23 by stress agents and oxidized LDL in cultured vascular smooth muscle cells.
FEBS Lett
368:239, 1995[Medline]
[Order article via Infotrieve]
68.
Toborek M, Kopieczna-Grzebieniak E, Drozdz M, Wieczorek M:
Increased lipid peroxidation as a mechanism of methionine-induced atherosclerosis in rabbits.
Atherosclerosis
115:217, 1995[Medline]
[Order article via Infotrieve]
69.
Prostko CR, Brostrom MA, Malara EM, Brostrom CO:
Phosphorylation of eukaryotic initiation factor (eIF) 2 and inhibition of eIF-2B in GH3 pituitary cell by perturbants of early protein processing that induce GRP78.
J Biol Chem
267:16751, 1992[Abstract/Free Full Text]
70.
Duncan G, Wormstone IM, Liu CS, Marcantonio JM, Davies PD:
Thapsigargin-coated intraocular lenses inhibit human lens cell growth.
Nature Med
3:1026, 1997[Medline]
[Order article via Infotrieve]
71.
Li XA, Lee AS:
Competitive inhibition of a set of endoplasmic reticulum protein genes (GRP78, GRP94, and Erp72) retards cell growth and lowers viability after ionophore treatment.
Mol Cell Biol
11:3446, 1991[Abstract/Free Full Text]
72.
George SJ, Johnson JL, Angelini GD, Jeremy JY:
Short-term exposure to thapsigargin inhibits neointima formation in human saphenous vein.
Arterioscler Thromb Vasc Biol
17:2500, 1997[Abstract/Free Full Text]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Zulli, E. Lau, B. P.P. Wijaya, X. Jin, K. Sutarga, G. D. Schwartz, J. Learmont, P. J. Wookey, A. Zinellu, C. Carru, et al.
High Dietary Taurine Reduces Apoptosis and Atherosclerosis in the Left Main Coronary Artery: Association With Reduced CCAAT/Enhancer Binding Protein Homologous Protein and Total Plasma Homocysteine but not Lipidemia
Hypertension,
June 1, 2009;
53(6):
1017 - 1022.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Gupta, J. Kuhnisch, A. Mustafa, S. Lhotak, A. Schlachterman, M. J. Slifker, A. Klein-Szanto, K. A. High, R. C. Austin, and W. D. Kruger
Mouse models of cystathionine {beta}-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia
FASEB J,
March 1, 2009;
23(3):
883 - 893.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-G. Zou, X.-Z. Cao, Y.-S. Zhao, S.-Y. Gao, S.-D. Li, X.-Y. Liu, Y. Zhang, and K.-Q. Zhang
The Molecular Mechanism of Endoplasmic Reticulum Stress-Induced Apoptosis in PC-12 Neuronal Cells: The Protective Effect of Insulin-Like Growth Factor I
Endocrinology,
January 1, 2009;
150(1):
277 - 285.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Hosoi, M. Sasaki, T. Miyahara, C. Hashimoto, S. Matsuo, M. Yoshii, and K. Ozawa
Endoplasmic Reticulum Stress Induces Leptin Resistance
Mol. Pharmacol.,
December 1, 2008;
74(6):
1610 - 1619.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. P. Malabanan, P. Kanellakis, A. Bobik, and L. M. Khachigian
Activation Transcription Factor-4 Induced by Fibroblast Growth Factor-2 Regulates Vascular Endothelial Growth Factor-A Transcription in Vascular Smooth Muscle Cells and Mediates Intimal Thickening in Rat Arteries Following Balloon Injury
Circ. Res.,
August 15, 2008;
103(4):
378 - 387.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. Feaver, N. E. Hastings, A. Pryor, and B. R. Blackman
GRP78 Upregulation by Atheroprone Shear Stress Via p38-, {alpha}2{beta}1-Dependent Mechanism in Endothelial Cells
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2008;
28(8):
1534 - 1541.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kitamura
Endoplasmic reticulum stress and unfolded protein response in renal pathophysiology: Janus faces
Am J Physiol Renal Physiol,
August 1, 2008;
295(2):
F323 - F334.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kerkeni, F. Added, M. B. Farhat, A. Miled, F. Trivin, and K. Maaroufi
Hyperhomocysteinaemia and parameters of antioxidative defence in Tunisian patients with coronary heart disease
Ann Clin Biochem,
March 1, 2008;
45(2):
193 - 198.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Leclerc and R. Rozen
Endoplasmic Reticulum Stress Increases the Expression of Methylenetetrahydrofolate Reductase through the IRE1 Transducer
J. Biol. Chem.,
February 8, 2008;
283(6):
3151 - 3160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Y.K. Lee, H.-F. Tse, C.-W. Siu, S.-G. Zhu, R. Y.K. Man, and P. M. Vanhoutte
Genomic Changes in Regenerated Porcine Coronary Arterial Endothelial Cells
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2007;
27(11):
2443 - 2449.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Forges, P. Monnier-Barbarino, J.M. Alberto, R.M. Gueant-Rodriguez, J.L. Daval, and J.L. Gueant
Impact of folate and homocysteine metabolism on human reproductive health
Hum. Reprod. Update,
May 1, 2007;
13(3):
225 - 238.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Colgan and R. C. Austin
Homocysteinylation of Metallothionein Impairs Intracellular Redox Homeostasis: The Enemy Within!
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2007;
27(1):
8 - 11.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Guzman, M. A. Navarro, R. Carnicer, A. J. Sarria, S. Acin, C. Arnal, P. Muniesa, J. C. Surra, J. M. Arbones-Mainar, N. Maeda, et al.
Cystathionine {beta}-synthase is essential for female reproductive function
Hum. Mol. Genet.,
November 1, 2006;
15(21):
3168 - 3176.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. K. Sen, S. Khanna, and S. Roy
Perceived hyperoxia: Oxygen-induced remodeling of the reoxygenated heart
Cardiovasc Res,
July 15, 2006;
71(2):
280 - 288.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. B. de Haan, P. K. Witting, N. Stefanovic, J. Pete, M. Daskalakis, I. Kola, R. Stocker, and J. J. Smolich
Lack of the antioxidant glutathione peroxidase-1 does not increase atherosclerosis in C57BL/J6 mice fed a high-fat diet
J. Lipid Res.,
June 1, 2006;
47(6):
1157 - 1167.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Galasso, S. Schiekofer, K. Sato, R. Shibata, D. E. Handy, N. Ouchi, J. A. Leopold, J. Loscalzo, and K. Walsh
Impaired Angiogenesis in Glutathione Peroxidase-1-Deficient Mice Is Associated With Endothelial Progenitor Cell Dysfunction
Circ. Res.,
February 3, 2006;
98(2):
254 - 261.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. F. Kamath, A. K. Chauhan, J. Kisucka, V. S. Dole, J. Loscalzo, D. E. Handy, and D. D. Wagner
Elevated levels of homocysteine compromise blood-brain barrier integrity in mice
Blood,
January 15, 2006;
107(2):
591 - 593.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. H. Werstuck, M. I. Khan, G. Femia, A. J. Kim, V. Tedesco, B. Trigatti, and Y. Shi
Glucosamine-Induced Endoplasmic Reticulum Dysfunction Is Associated With Accelerated Atherosclerosis in a Hyperglycemic Mouse Model
Diabetes,
January 1, 2006;
55(1):
93 - 101.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. Dickhout, G. S. Hossain, L. M. Pozza, J. Zhou, S. Lhotak, and R. C. Austin
Peroxynitrite Causes Endoplasmic Reticulum Stress and Apoptosis in Human Vascular Endothelium: Implications in Atherogenesis
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2005;
25(12):
2623 - 2629.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Zhou, W. M. Pandak Jr., V. Lyall, R. Natarajan, and P. B. Hylemon
HIV Protease Inhibitors Activate the Unfolded Protein Response in Macrophages: Implication for Atherosclerosis and Cardiovascular Disease
Mol. Pharmacol.,
September 1, 2005;
68(3):
690 - 700.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. W. H. Woo, Y. L. Siow, G. N. Pierce, P. C. Choy, G. Y. Minuk, D. Mymin, and K. O
Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors
Am J Physiol Endocrinol Metab,
May 1, 2005;
288(5):
E1002 - E1010.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Handy, Y. Zhang, and J. Loscalzo
Homocysteine Down-regulates Cellular Glutathione Peroxidase (GPx1) by Decreasing Translation
J. Biol. Chem.,
April 22, 2005;
280(16):
15518 - 15525.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bosch-Marce, R. Pola, A. B Wecker, M. Silver, A. Weber, C. Luedemann, C. Curry, T. Murayama, M. Kearney, Y.-s. Yoon, et al.
Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemia
Vascular Medicine,
February 1, 2005;
10(1):
15 - 22.
[Abstract]
[PDF]
|
|
|
|
|
|
|
X.-m. Liu, K. J. Peyton, D. Ensenat, H. Wang, A. I. Schafer, J. Alam, and W. Durante
Endoplasmic Reticulum Stress Stimulates Heme Oxygenase-1 Gene Expression in Vascular Smooth Muscle: ROLE IN CELL SURVIVAL
J. Biol. Chem.,
January 14, 2005;
280(2):
872 - 877.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Kim, Y. Shi, R. C. Austin, and G. H. Werstuck
Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3
J. Cell Sci.,
January 1, 2005;
118(1):
89 - 99.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Namekata, Y. Enokido, I. Ishii, Y. Nagai, T. Harada, and H. Kimura
Abnormal Lipid Metabolism in Cystathionine {beta}-Synthase-deficient Mice, an Animal Model for Hyperhomocysteinemia
J. Biol. Chem.,
December 17, 2004;
279(51):
52961 - 52969.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Di Simone, P. Riccardi, N. Maggiano, A. Piacentani, M. D'Asta, A. Capelli, and A. Caruso
Effect of folic acid on homocysteine-induced trophoblast apoptosis
Mol. Hum. Reprod.,
September 1, 2004;
10(9):
665 - 669.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Zhou, G. H. Werstuck, S. Lhotak, A. B. L. de Koning, S. K. Sood, G. S. Hossain, J. Moller, M. Ritskes-Hoitinga, E. Falk, S. Dayal, et al.
Association of Multiple Cellular Stress Pathways With Accelerated Atherosclerosis in Hyperhomocysteinemic Apolipoprotein E-Deficient Mice
Circulation,
July 13, 2004;
110(2):
207 - 213.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Skurk and K. Walsh
Death Receptor Induced Apoptosis: A New Mechanism of Homocysteine-Mediated Endothelial Cell Cytotoxicity
Hypertension,
June 1, 2004;
43(6):
1168 - 1170.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. N. Roybal, S. Yang, C.-W. Sun, D. Hurtado, D. L. Vander Jagt, T. M. Townes, and S. F. Abcouwer
Homocysteine Increases the Expression of Vascular Endothelial Growth Factor by a Mechanism Involving Endoplasmic Reticulum Stress and Transcription Factor ATF4
J. Biol. Chem.,
April 9, 2004;
279(15):
14844 - 14852.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Monaco and E. Paleolog
Nuclear factor {kappa}B: a potential therapeutic target in atherosclerosis and thrombosis
Cardiovasc Res,
March 1, 2004;
61(4):
671 - 682.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Rodrigo, W. Passalacqua, J. Araya, M. Orellana, and G. Rivera
Homocysteine and Essential Hypertension
J. Clin. Pharmacol.,
December 1, 2003;
43(12):
1299 - 1306.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Majors, R. C. Austin, C. A. de la Motte, R. E. Pyeritz, V. C. Hascall, S. P. Kessler, G. Sen, and S. A. Strong
Endoplasmic Reticulum Stress Induces Hyaluronan Deposition and Leukocyte Adhesion
J. Biol. Chem.,
November 21, 2003;
278(47):
47223 - 47231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Robert, J.-F. Chasse, D. Santiard-Baron, C. Vayssettes, A. Chabli, J. Aupetit, N. Maeda, P. Kamoun, J. London, and N. Janel
Altered Gene Expression in Liver from a Murine Model of Hyperhomocysteinemia
J. Biol. Chem.,
August 22, 2003;
278(34):
31504 - 31511.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. S. Hossain, J. V. van Thienen, G. H. Werstuck, J. Zhou, S. K. Sood, J. G. Dickhout, A. B. L. de Koning, D. Tang, D. Wu, E. Falk, et al.
TDAG51 Is Induced by Homocysteine, Promotes Detachment-mediated Programmed Cell Death, and Contributes to the Development of Atherosclerosis in Hyperhomocysteinemia
J. Biol. Chem.,
August 8, 2003;
278(32):
30317 - 30327.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Watson, A. K. C. Chan, L. R. Berry, J. Li, S. K. Sood, J. G. Dickhout, L. Xu, G. H. Werstuck, L. Bajzar, H. J. Klamut, et al.
Overexpression of the 78-kDa Glucose-regulated Protein/Immunoglobulin-binding Protein (GRP78/BiP) Inhibits Tissue Factor Procoagulant Activity
J. Biol. Chem.,
May 2, 2003;
278(19):
17438 - 17447.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q. Shi, J. E. Savage, S. J. Hufeisen, L. Rauser, E. Grajkowska, P. Ernsberger, J. T. Wroblewski, J. H. Nadeau, and B. L. Roth
L-Homocysteine Sulfinic Acid and Other Acidic Homocysteine Derivatives Are Potent and Selective Metabotropic Glutamate Receptor Agonists
J. Pharmacol. Exp. Ther.,
April 1, 2003;
305(1):
131 - 142.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. Roy, S. Khanna, A. A. Bickerstaff, S. V. Subramanian, M. Atalay, M. Bierl, S. Pendyala, D. Levy, N. Sharma, M. Venojarvi, et al.
Oxygen Sensing by Primary Cardiac Fibroblasts: A Key Role of p21Waf1/Cip1/Sdi1
Circ. Res.,
February 21, 2003;
92(3):
264 - 271.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Dayal, K. L. Brown, C. J. Weydert, L. W. Oberley, E. Arning, T. Bottiglieri, F. M. Faraci, and S. R. Lentz
Deficiency of Glutathione Peroxidase-1 Sensitizes Hyperhomocysteinemic Mice to Endothelial Dysfunction
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2002;
22(12):
1996 - 2002.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Grove, V. V. Prabhu, B. L. Young, F. C. Lee, V. Kulpa, P. J. Munson, and E. C. Kohn
Both Protein Activation and Gene Expression Are Involved in Early Vascular Tube Formation in Vitro
Clin. Cancer Res.,
September 1, 2002;
8(9):
3019 - 3026.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Forgione, A. Cap, R. Liao, N. I. Moldovan, R. T. Eberhardt, C. C. Lim, J. Jones, P. J. Goldschmidt-Clermont, and J. Loscalzo
Heterozygous Cellular Glutathione Peroxidase Deficiency in the Mouse: Abnormalities in Vascular and Cardiac Function and Structure
Circulation,
August 27, 2002;
106(9):
1154 - 1158.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Weiss, C. Keller, U. Hoffmann, and J. Loscalzo
Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia
Vascular Medicine,
August 1, 2002;
7(3):
227 - 239.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. Weiss, S. Heydrick, Y.-Y. Zhang, C. Bierl, A. Cap, and J. Loscalzo
Cellular Redox State and Endothelial Dysfunction in Mildly Hyperhomocysteinemic Cystathionine {beta}-Synthase-Deficient Mice
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2002;
22(1):
34 - 41.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Weiss, Y.-Y. Zhang, S. Heydrick, C. Bierl, and J. Loscalzo
Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction
PNAS,
October 12, 2001;
(2001)
231428998.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Zhou, J. Moller, C. C. Danielsen, J. Bentzon, H. B. Ravn, R. C. Austin, and E. Falk
Dietary Supplementation With Methionine and Homocysteine Promotes Early Atherosclerosis but Not Plaque Rupture in ApoE-Deficient Mice
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2001;
21(9):
1470 - 1476.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. BESSEDE, C. MIGUET, P. GAMBERT, D. NEEL, and G. LIZARD
Efficiency of homocysteine plus copper in inducing apoptosis is inversely proportional to {gamma}-glutamyl transpeptidase activity
FASEB J,
September 1, 2001;
15(11):
1927 - 1940.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Poddar, N. Sivasubramanian, P. M. DiBello, K. Robinson, and D. W. Jacobsen
Homocysteine Induces Expression and Secretion of Monocyte Chemoattractant Protein-1 and Interleukin-8 in Human Aortic Endothelial Cells : Implications for Vascular Disease
Circulation,
June 5, 2001;
103(22):
2717 - 2723.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R.-F. S. Huang, Y.-C. Hsu, H.-L. Lin, and F. L. Yang
Folate Depletion and Elevated Plasma Homocysteine Promote Oxidative Stress in Rat Livers
J. Nutr.,
January 1, 2001;
131(1):
33 - 38.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. Duan, T. Murohara, H. Ikeda, K.-i. Sasaki, S. Shintani, T. Akita, T. Shimada, and T. Imaizumi
Hyperhomocysteinemia Impairs Angiogenesis in Response to Hindlimb Ischemia
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2000;
20(12):
2579 - 2585.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. I. Stangl, D. A. Roth-Maier, and M. Kirchgessner
Vitamin B-12 Deficiency and Hyperhomocysteinemia Are Partly Ameliorated by Cobalt and Nickel Supplementation in Pigs
J. Nutr.,
December 1, 2000;
130(12):
3038 - 3044.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Cai, C. Zhang, T. Nawa, T. Aso, M. Tanaka, S. Oshiro, H. Ichijo, and S. Kitajima
Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH2-terminal kinase and promoter response element
Blood,
September 15, 2000;
96(6):
2140 - 2148.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Lentz, R. A. Erger, S. Dayal, N. Maeda, M. R. Malinow, D. D. Heistad, and F. M. Faraci
Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta -synthase-deficient mice
Am J Physiol Heart Circ Physiol,
September 1, 2000;
279(3):
H970 - H975.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. P. Simeonova, S. Wang, W. Toriuma, V. Kommineni, J. Matheson, N. Unimye, F. Kayama, D. Harki, M. Ding, V. Vallyathan, et al.
Arsenic Mediates Cell Proliferation and Gene Expression in the Bladder Epithelium: Association with Activating Protein-1 Transactivation
Cancer Res.,
July 1, 2000;
60(13):
3445 - 3453.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K. Kokame, K. L. Agarwala, H. Kato, and T. Miyata
Herp, a New Ubiquitin-like Membrane Protein Induced by Endoplasmic Reticulum Stress
J. Biol. Chem.,
October 13, 2000;
275(42):
32846 - 32853.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Zhang, Y. Cai, M. T. Adachi, S. Oshiro, T. Aso, R. J. Kaufman, and S. Kitajima
Homocysteine Induces Programmed Cell Death in Human Vascular Endothelial Cells through Activation of the Unfolded Protein Response
J. Biol. Chem.,
September 14, 2001;
276(38):
35867 - 35874.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. H. He, P. Gong, B. Hu, D. Stewart, M. E. Choi, A. M. K. Choi, and J. Alam
Identification of Activating Transcription Factor 4 (ATF4) as an Nrf2-interacting Protein. IMPLICATION FOR HEME OXYGENASE-1 GENE REGULATION
J. Biol. Chem.,
June 8, 2001;
276(24):
20858 - 20865.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Weiss, Y.-Y. Zhang, S. Heydrick, C. Bierl, and J. Loscalzo
Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction
PNAS,
October 23, 2001;
98(22):
12503 - 12508.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
TOP
ABSTRACT
INTRODUCTION